Multiple myeloma trials in Slovenia

1 trial · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  Where

  Ljubljana, Maribor

  Age

  18 years and over

  People

  492 worldwide

  Run by

  Pfizer

  See details and how to joinNCT06152575 · EU 2023-507871-23-00